The rise of Sildenafil initially drove a boom for major pharmaceutical companies, however recent developments present a uncertain scenario for shareholders. Lower-cost alternatives are reducing profits, and ongoing https://amieijcr262634.pages10.com/sildenafil-and-the-pharmaceutical-industry-a-volatile-investment-76596859